These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 26595821)
1. GATA3 Expression in Normal Skin and in Benign and Malignant Epidermal and Cutaneous Adnexal Neoplasms. Mertens RB; de Peralta-Venturina MN; Balzer BL; Frishberg DP Am J Dermatopathol; 2015 Dec; 37(12):885-91. PubMed ID: 26595821 [TBL] [Abstract][Full Text] [Related]
2. GATA3 and MYB Expression in Cutaneous Adnexal Neoplasms. Pardal J; Sundram U; Selim MA; Hoang MP Am J Dermatopathol; 2017 Apr; 39(4):279-286. PubMed ID: 28323779 [TBL] [Abstract][Full Text] [Related]
3. Expression of Bcl-x in normal skin and benign cutaneous adnexal tumors. Thamboo TP; Tan LH; Tan SY J Cutan Pathol; 2006 Jan; 33(1):27-32. PubMed ID: 16441408 [TBL] [Abstract][Full Text] [Related]
4. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma. Plumb SJ; Argenyi ZB; Stone MS; De Young BR Am J Dermatopathol; 2004 Dec; 26(6):447-51. PubMed ID: 15618924 [TBL] [Abstract][Full Text] [Related]
5. GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract. Howitt BE; Emori MM; Drapkin R; Gaspar C; Barletta JA; Nucci MR; McCluggage WG; Oliva E; Hirsch MS Am J Surg Pathol; 2015 Oct; 39(10):1411-9. PubMed ID: 26135559 [TBL] [Abstract][Full Text] [Related]
6. GATA3 staining in primary cutaneous apocrine cribriform carcinoma: Usefulness to differentiate it from breast cancer metastasis. Llamas-Velasco M; Pérez-Gónzalez YC; Daudén E; Rütten A J Cutan Pathol; 2018 May; 45(5):348-351. PubMed ID: 29431200 [TBL] [Abstract][Full Text] [Related]
7. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases. Plaza JA; Ortega PF; Stockman DL; Suster S J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670 [TBL] [Abstract][Full Text] [Related]
8. GATA3 immunohistochemical expression in salivary gland neoplasms. Schwartz LE; Begum S; Westra WH; Bishop JA Head Neck Pathol; 2013 Dec; 7(4):311-5. PubMed ID: 23604756 [TBL] [Abstract][Full Text] [Related]
9. GATA3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial tumors. Miettinen M; McCue PA; Sarlomo-Rikala M; Rys J; Czapiewski P; Wazny K; Langfort R; Waloszczyk P; Biernat W; Lasota J; Wang Z Am J Surg Pathol; 2014 Jan; 38(1):13-22. PubMed ID: 24145643 [TBL] [Abstract][Full Text] [Related]
10. [Skin adnexal and salivary gland neoplasms. Similarities and differences of selected patients]. Mentzel T Pathologe; 2004 Feb; 25(1):79-88. PubMed ID: 14767616 [TBL] [Abstract][Full Text] [Related]
11. SOX10 immunohistochemistry in sweat ductal/glandular neoplasms. Cassarino DS; Su A; Robbins BA; Altree-Tacha D; Ra S J Cutan Pathol; 2017 Jun; 44(6):544-547. PubMed ID: 28343365 [TBL] [Abstract][Full Text] [Related]
12. Sox10 and DOG1 Expression in Primary Adnexal Tumors of the Skin. Lezcano C; Ho J; Seethala RR Am J Dermatopathol; 2017 Dec; 39(12):896-902. PubMed ID: 28394798 [TBL] [Abstract][Full Text] [Related]
13. Cytokeratin 20: a marker for diagnosing Merkel cell carcinoma. Scott MP; Helm KF Am J Dermatopathol; 1999 Feb; 21(1):16-20. PubMed ID: 10027519 [TBL] [Abstract][Full Text] [Related]
14. The expression of CD23 in cutaneous non-lymphoid neoplasms. Carvalho J; Fullen D; Lowe L; Su L; Ma L J Cutan Pathol; 2007 Sep; 34(9):693-8. PubMed ID: 17696916 [TBL] [Abstract][Full Text] [Related]
15. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a sensitive and specific marker to discriminate sebaceous proliferations from other cutaneous clear cell neoplasms. Uhlenhake EE; Clark LN; Smoller BR; Shalin SC; Gardner JM J Cutan Pathol; 2016 Aug; 43(8):649-56. PubMed ID: 27153339 [TBL] [Abstract][Full Text] [Related]
16. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases. Ostler DA; Prieto VG; Reed JA; Deavers MT; Lazar AJ; Ivan D Mod Pathol; 2010 Apr; 23(4):567-73. PubMed ID: 20118912 [TBL] [Abstract][Full Text] [Related]
17. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. Ivan D; Nash JW; Prieto VG; Calonje E; Lyle S; Diwan AH; Lazar AJ J Cutan Pathol; 2007 Jun; 34(6):474-80. PubMed ID: 17518775 [TBL] [Abstract][Full Text] [Related]
18. p53 expression in sweat gland tumors. Biernat W; Woźniak L Pol J Pathol; 1996; 47(1):3-6. PubMed ID: 8705267 [TBL] [Abstract][Full Text] [Related]
19. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin. Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777 [TBL] [Abstract][Full Text] [Related]
20. Distinctive immunostaining of claudin-4 in spiradenomas. Yiğit N; Çelik E; Yavan İ; Günal A; Kurt B; Karslıoğlu Y; Öngürü Ö; Özcan A Ann Diagn Pathol; 2016 Feb; 20():44-7. PubMed ID: 26616722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]